Empowering Biotech Innovations with Advanced Solutions
Since 2023, AmyGo Solutions has studied the molecular structures behind systemic amyloidosis to develop diagnostics and therapeutics that address the disease at its root cause, enabling earlier detection and more personalized treatment.
Â
Beyond the lab, we work alongside patients, caregivers, and healthcare professionals to ensure comprehensive care at every step, integrating our solutions with existing healthcare ecosystems to maximize their real-world impact.
Our mission is to develop cutting-edge diagnostics for early detection of amyloidosis.
0
Blood Tests Currently Exist Specifically for This Disease
95%
Test Sensitivity
600+
Blood Samples Validated
For too long, patients with this disease have had no reliable way to be diagnosed early. AmyGo Solutions's blood test changes that, delivering 95% sensitivity across a validation set of more than 600 blood samples. It's a simple, non-invasive test built to catch this disease before permanent damage occurs, giving physicians the tool they've never had.
